Arylomycin A2
Also known as: Arylomycin A-2, Arylomycin A₂, Compound A2
Source Arylomycin A2 at Peptiology
Save 10% with code PEPTI-BOSSRABBIT-10
Tapping Shop Now & Save 10% copies your 10% off code PEPTI-BOSSRABBIT-10 to your clipboard. Paste it at the Peptiology checkout to claim the discount.
Summary
Arylomycin A2 is a natural lipopeptide derived from marine actinomycetes that exhibits potent activity against Gram‑positive bacteria by targeting signal peptidase I. It is being explored as a lead for novel antibiotics against resistant pathogens.
Mechanism of Action
Selective inhibition of bacterial type I signal peptidase (SPase I), blocking cleavage of preproteins and impairing cell wall synthesis
Routes of Administration
Goals & Uses
- Antibiotic developmentInfectious DiseaseModerate
- Antibacterial activity against Gram-positive bacteriaAntimicrobialModerate
- Scaffold for antibiotic drug discoveryDrug DiscoveryModerate
- Target validation of type I signal peptidaseResearch ToolHigh
Contraindications
- Human use / clinical administrationRegulatoryHigh
Adverse Effects
- Cytotoxicity (in vitro)ToxicityUnknown
Drug Interactions
No drug interactions recorded yet.
Population Constraints
- General human populationRegulatory/safetyAbsolute
Regulatory Status
- European UnionUnapprovedNo clinical evaluation yet
- United StatesUnapprovedPreclinical candidate; not submitted to FDA
- United KingdomUnapprovedNo regulatory filing or approval; research use only.
No regulatory approval; currently in preclinical/early‑stage investigational studies.
Evidence & Sources
No sources recorded yet.
Frequently Asked Questions
What is Arylomycin A2?
Arylomycin A2 is a natural lipopeptide derived from marine actinomycetes that exhibits potent activity against Gram‑positive bacteria by targeting signal peptidase I. It is being explored as a lead for novel antibiotics against resistant pathogens.
What is Arylomycin A2 used for?
Arylomycin A2 is educationally associated with: Antibiotic development, Antibacterial activity against Gram-positive bacteria, Scaffold for antibiotic drug discovery, Target validation of type I signal peptidase. Educational only — not medical advice.
How is Arylomycin A2 administered?
Recorded routes of administration: Intravenous, Subcutaneous.
What are the potential side effects of Arylomycin A2?
Reported adverse effects include: Cytotoxicity (in vitro). This list is not exhaustive — consult a qualified clinician.
Who should avoid Arylomycin A2?
Recorded contraindications: Human use / clinical administration. Consult a qualified clinician before use.